Methods of treating acute inflammation in animals with p38 MAP kinase inhibitors

Details for Australian Patent Application No. 2004305318 (hide)

Owner Pfizer Products Inc.

Inventors Sakya, Subas Man; Kehrli, Marcus Eugene Jr.

Agent Shelston IP

Pub. Number AU-A-2004305318

PCT Pub. Number WO2005/060967

Priority 60/530,722 18.12.03 US

Filing date 6 December 2004

Wipo publication date 7 July 2005

International Classifications

A61K 31/497 (2006.01)

A61K 31/00 (2006.01)

A61K 31/4184 (2006.01)

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/4439 (2006.01)

A61K 31/4745 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/060967 Priority application(s): WO2005/060967

25 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004305319-Polycrystalline diamond abrasive elements

2004305317-Pyrrolo [2,3-D] pyrimidine compounds for treating transplant rejection